HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanistic target of rapamycin (mTOR) dependent regulation of thioredoxin interacting protein (TXNIP) transcription in hypoxia.

Abstract
Thioredoxin interacting protein (TXNIP), first identified as an inhibitor of thioredoxin, is also a tumor suppressor as well as an inhibitor of lipogenesis. TXNIP is known to be transcriptionally regulated in response to nutrients such as glucose and stress signals, including endoplasmic reticulum stress and lactic acidosis. In this study, we characterized the transcriptional regulation of TXNIP in response to hypoxia. Using a hepatocellular carcinoma cell line, we have found that TXNIP mRNA expression is regulated in a biphasic manner in hypoxia whereby TXNIP expression showed an initial rapid decrease, followed by an increase under prolonged hypoxia. Interestingly, we have shown that TXNIP induction in prolonged hypoxia is independent of the Hypoxia-Inducible Factor (HIF) transcription factor. The effect of hypoxia on TXNIP expression is mediated via the inhibition of the 4E-BP1/eIF4E axis of mechanistic target of rapamycin (mTORC1). Thus, we found that inhibiting mTORC1-dependent 4E-BP1 phosphorylation mimics the effect of hypoxia on TXNIP expression. Furthermore, overexpressing eIF4E prevents the induction of TXNIP in hypoxia. Our results suggest that mTORC1 may be an important regulator of hypoxia-dependent gene expression.
AuthorsRegina Wanju Wong, Thilo Hagen
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 433 Issue 1 Pg. 40-6 (Mar 29 2013) ISSN: 1090-2104 [Electronic] United States
PMID23454121 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • ARNT protein, human
  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Cell Cycle Proteins
  • EIF4EBP1 protein, human
  • Eif4ebp1 protein, mouse
  • Enzyme Inhibitors
  • Eukaryotic Initiation Factors
  • Multiprotein Complexes
  • Phosphoproteins
  • Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • TXNIP protein, human
  • Txnip protein, mouse
  • Aryl Hydrocarbon Receptor Nuclear Translocator
  • Thioredoxins
  • Procollagen-Proline Dioxygenase
  • MTOR protein, human
  • mTOR protein, mouse
  • Mechanistic Target of Rapamycin Complex 1
  • TOR Serine-Threonine Kinases
Topics
  • Adaptor Proteins, Signal Transducing (antagonists & inhibitors)
  • Animals
  • Aryl Hydrocarbon Receptor Nuclear Translocator (antagonists & inhibitors, genetics, metabolism)
  • Base Sequence
  • Carrier Proteins (antagonists & inhibitors, biosynthesis, genetics)
  • Cell Cycle Proteins
  • Cell Hypoxia (genetics, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Eukaryotic Initiation Factors
  • Gene Expression Regulation (drug effects)
  • HEK293 Cells
  • Hep G2 Cells
  • Humans
  • Mechanistic Target of Rapamycin Complex 1
  • Mice
  • Multiprotein Complexes
  • NIH 3T3 Cells
  • Phosphoproteins (antagonists & inhibitors)
  • Procollagen-Proline Dioxygenase (antagonists & inhibitors)
  • Proteins (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • TOR Serine-Threonine Kinases (metabolism)
  • Thioredoxins (biosynthesis, genetics)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: